Suheyla GORAR, ESRA NUR ADEMOĞLU DİLEKÇİ, Seyit UYAR, Mehmet KÖK, Bülent ÇEKİÇ, İsmail GÖMCELİ

Bir Adrenal İnsidentaloma Olgusu: Kontrolsüz Diabetes Mellitus Takibinde Feokromositoma Tanısı

Adrenal insidentalomalar radyolojik değerlendirmeler sırasında rastlantısal olarak tespit edilen kitlelerdir. Açıklanması gereken 2 temel soru, kitlenin hormonal aktivitesi ve malign olup olmadığıdır. Radyolojik yöntemlerle elde edilen görüntüleme özellikleri çok önemli ve ayrıca tanıda yol göstericidirler. Lezyondan tanısal biyopsi de yapılabilir ancak rutin takipte önerilmez. Hormonal açıdan lezyonların çoğu nonfonksiyone olmakla birlikte, olgular farklı klinik bulgu ve semptomlara sahip olabilirler ve bunlar insidental kitle tespit edilinceye kadar klinisyenin dikkatini çekmeyebilir. Bizim olgumuzda, tedavi modifikasyonlarına rağmen kan şekeri kontrolü sağlanamaması nedeniyle araştırılırken insidental adrenal kitle tespit edildi. Yapılan tetkikler ve takip sonucunda, asemptomatik bir feokromositoma olgusu ile karşılaştığımızı gördük. Cerrahi tedavi ile hastanın hem klinik hem de laboratuvar stabilizasyonu sağlandı.

A Case of Adrenal Incidentaloma: Diagnosed Pheochromocytoma during Uncontrolled Diabetes Mellitus Follow-up

Adrenal incidentalomas are serendipitously discovered by radiologic examination. Whether malignant mass and hormonal activity are two basic questions that need to be explained. Obtained radiological imaging features are very important and they are also guiding for diagnosis. Diagnostic biopsy of the lesion can be done but not used in routine. Although the majority of lesions in terms of hormonal activity are nonfunctional, patients can have different signs and symptoms. Therefore, they can't attract the attention of the clinician until incidentally detected mass. Despite treatment modifications, we can not be achieved diabetic control in our case. We detected adrenal incidentaloma during follow-up, we are faced with an asymptomatic cases of pheochromocytoma. Surgical treatment was provided with both laboratory and clinical stabilization of the patients.

PDF

___

1. Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V, Zini M, Borretta G, Papini E, Garofalo P, Allolio B, Dupas B, Mantero F, Tabarin A; Italian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma. Eur J Endocrinol. 2011;164(6):851-70.
2. Cawood TJ, Hunt PJ, O'Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol. 2009;161(4):513.
3. Angeli A, Osella G, AlìA, Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res. 1997;47(4- 6):279.
4. Tütüncü NB. Adrenal insidentalomalar. Turkish Journal of Endocrinology and Metabolism. 2003;7.
5. Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A, Bravo EL. Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab. 2005;90(2):871-7.
6. Peña CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology. 2000;217(3):798.
7. Boland GW, Lee MJ. Magnetic resonance imaging of the adrenal gland.Crit Rev Diagn Imaging. 1995;36(2):115-74.
8. Casola G, Nicolet V, vanSonnenberg E, Withers C, Bretagnolle M, Saba RM, Bret PM. Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy. Radiology. 1986;159(3):733.
9. AACE/AAES Adrenal Incidentaloma Guidelines, Endocr Pract. 2009;15(Suppl 1). 10. Manger WM, Gifford RW. Pheochromocytoma. J Clin Hypertens (Greenwich). 2002;4(1):62.
11. Roy M, Sengupta N, Sahana PK, Giri D, Das C. A case of normotensive pheochromocytoma with management dilemma.Indian J Endocrinol Metab. 2012;16(2):371-2.
12. Klingler PJ, Fox TP, Menke DM, Knudsen JM, Fulmer JT. Pheochromocytoma in an incidentally discovered asymptomatic cystic adrenal mass.Mayo Clin Proc. 2000;75(5):517-20.
13. Sawka AM, Jaeschke R, Singh RJ, Young WF Jr J. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. Clin Endocrinol Metab. 2003;88(2):553.
14. Plouin PF, Degoulet P, Tugayé A, Ducrocq MB, Ménard J. Screening for phaeochromocytoma: In which hypertensive patients. A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)? Nouv Presse Med. 1981;10:869-72.
15. Young WF, Kaplan MN, Kebebew E. The adrenal incidentaloma. www.uptodate.com access date 30.06.2014